Código QR (código de barras bidimensional)

Losmapimod Overcomes Gefitinib Resistance in Non-small Cell Lung Cancer by Preventing Tetraploidization

The epidermal growth factor receptor (EGFR) is known to play a critical role in non-small cell lung cancer (NSCLC). Constitutively active EGFR mutations, including in-frame deletion in exon 19 and L858R point mutation in exon 21, contribute about 90% of all EGFR-activating mutations in NSCLC. Althou...

ver descrição completa

Na minha lista:
Principais autores: Yiu To Yeung, Shuying Yin, Bingbing Lu, Suyu Fan, Ran Yang, Ruihua Bai, Chengjuan Zhang, Ann M. Bode, Kangdong Liu, Zigang Dong
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2018-02-01
coleção:EBioMedicine
Assuntos:
Non-small cell lung cancer (NSCLC)
Gefitinib resistance
Tetraploidization
p38 mitogen activating protein kinase (MAPK)
Losmapimod
Acesso em linha:http://www.sciencedirect.com/science/article/pii/S2352396418300215
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados